Pastides to Chair SC Institute of Medicine & Public Health Board see more
The South Carolina Institute of Medicine & Public Health (IMPH) is pleased to announce new executive officers and members of the Board of Directors. Dr. Harris Pastides has been named Chair and Mr. Joel A. Smith III Vice-Chair. Dr. Pastides is President of the University of South Carolina. Mr. Joel Smith is Dean Emeritus, University of South Carolina Moore School of Business and President (retired) of Bank of America East and will be serving a second term in this role. Ms. Pamela Lackey, President (retired), AT&T South Carolina, is the immediate past Chair.
Dr. Pastides shared, “I am honored to serve as Chair of the Board of Directors for the South Carolina Institute of Medicine & Public Health. South Carolina continues to face persistent and emerging health challenges while the health care and public health systems are adapting to new technologies and payment models. IMPH is uniquely situated to share nonpartisan, evidence-based policy solutions, and I look forward to advancing these matters of importance for all South Carolinians.”
Joining the board for the first time for the 2019-2021 term is Ms. Lou Kennedy, President, Chief Executive Officer and Owner, Nephron Pharmaceuticals Corporation. Ms. Kennedy joined Nephron Pharmaceuticals in 2001 and accepted the position of President and Chief Executive Officer in September 2007. She is currently the new chairman of the South Carolina Chamber of Commerce. She is also involved in a variety of other business and civic boards, including but not limited to, the National Bank of South Carolina Board, USC Athletic Department Board, Columbia College Board of Trustees and the South Carolina Manufacturers Alliance.
Dr. David Cole, President, Medical University of South Carolina; Mr. Joel A. Smith III, Dean Emeritus, University of South Carolina Moore School of Business and President (retired) of Bank of America East; and Mr. Richard Wilkerson, Chairman and President (retired), Michelin North America were all elected for renewed terms to serve 2019-2021.
“I have the privilege of working with an incredible board dedicated to improving health and health care in South Carolina, said Executive Director Kester Freeman. “Ms. Lackey’s vision and leadership has steadily guided the IMPH Board of Directors for the past two years, and I am thankful she will continue her term of service on our board through 2020. Mr. Smith’s re-election as Vice-Chair provides additional continuity of leadership on the executive committee as Dr. Pastides becomes Chair. I am thrilled Dr. Pastides has agreed to provide his leadership and vision as we continue to grow the Institute.”
During the past year, IMPH has undergone an intensive strategic planning process and assessment of operational roles and functions. As a result, new organizational roles have been established to better meet the needs of the Institute. Co-directors Ms. Maya Pack and Dr. Megan Weis will start their new roles effective January 1, 2019.
Ms. Maya Pack will serve as Associate Executive Director. She will continue to lead business and financial management of the Institute, and will now manage all programs and contracts including SCale Down, Behavioral Health and Long-Term Care, the Health Policy Fellows Program and other legislative services.
Dr. Megan Weis will serve as Senior Director of Strategic Engagement to build and expand the Institute’s communications, impact evaluation and development work, as well as continuing to foster relationships in-state and nationally.
With the support of the Board of Directors and the continued executive leadership of Mr. Freeman, these updates will support IMPH’s vision to be the leading and trusted nonpartisan resource for research-based information on South Carolina’s most critical public health issues.
IMPH Board of Directors
- Dr. Harris Pastides, (chair), President, University of South Carolina
- Mr. Joel A. Smith III, (vice-chair), Dean Emeritus, USC Moore School of Business; President (retired), Bank of America East
- The Honorable Terry Alexander, Member, South Carolina House of Representatives
- Mr. William Barnet, CEO, Barnet Development
- Dr. David J. Cole, President, Medical University of South Carolina
- The Honorable Ronnie Cromer, Member, South Carolina Senate
- The Honorable Jim Hodges, President and CEO, McGuireWoods Consulting, LLC; Former Governor, State of South Carolina
- Dr. Chanita Hughes-Halbert, Professor, Medical University of South Carolina
- Ms. Lou Kennedy, President, Chief Executive Officer and Owner, Nephron Pharmaceuticals Corporation
- Ms. Pamela Lackey, President (retired), AT&T South Carolina
- Mr. Ed Sellers, Chairman, Board of Directors, BlueCross BlueShield of South Carolina
- The Honorable Inez M. Tenenbaum, Of Counsel, Wyche P.A.; Former Chairman, U.S. Consumer Product
- Safety Commission; Former Superintendent of Education, State of South Carolina
- Dr. Windsor Westbrook Sherrill, Associate Vice President for Health Research, Clemson University; Chief Science Officer, Greenville Health System
- Mr. Richard Wilkerson, Chairman and President (retired), Michelin North America
- Dr. Gerald Wilson, Surgeon (retired), Midlands Surgical Associates
SCHA has awarded funds to two South Carolina universities to support healthcare programs see more
The S.C. Hospital Association has awarded the University of South Carolina and Clemson University $25,000 each to support the development of health care programs at the schools.
USC will use the gift to its Department of Health Services Policy and Management in the Arnold School of Public Health to support students in its master’s of health administration program, while Clemson will use the money to create interprofessional clinical learning opportunities in its School of Nursing’s partnership with Greenville Health System, according to a news release.
Additional funding may be provided after two years based on an annual review.
“The SCHA scholarship will help the MHA program as it prepares students for positions to advance the provision of effective, efficient and equitable health services in South Carolina,” said Bankole Olatosi, director of USC’s master’s of health administration program. “Our students will benefit from the increased access to professional education available through conferences, meetings and training to complement their education. Such opportunities will also be used as a marketing tool for recruiting more talented future health administrators to South Carolina.”
The scholarship program is funded by SCHA Solutions, a division of the hospital association that works with companies to provide services to state hospitals and health systems. Companies earn program endorsement by negotiating the best price for services and revenue sharing that support SCHA priorities, including workforce development.
“We're grateful for the South Carolina Hospital Association's support of our efforts to ensure that our graduates are well-prepared,” said Kathleen Valentine, Clemson School of Nursing director. “Through these funds, students will have increased access to experts in the fields of interprofessional teamwork, continuum of care, population health and community health. We want to make students aware of career opportunities within hospitals and in communities that extend the rich contributions nurses offer to patients and families and enable nurses to thrive within their professional role.”
Founded in 1921, Columbia-based SCHA advocates for the more than 70,000 workers employed in the state’s hospitals and health care systems.
“SCHA recently completed on-site meetings with leaders of every hospital in the state to learn more about their issues and challenges. Topping the list was recruiting and retaining a quality workforce,” said Lara Hewitt, SCHA Solutions vice president for workforce and partner engagement. “That makes it our priority, and we're pleased to be able to award these grants to help prepare the next generation of health care staff.”
Chad Hardaway discusses The Office of Economic Engagement at the University of South Carolina and its newest programsChad Hardaway of USC discusses new programs in this interview. see more
The Office of Economic Engagement (OEE) was formed in 2013 at the University of South Carolina to better connect businesses with the resources of a top-tier research institution.
The OEE offers businesses one point of contact at the university. Four critical functions are now all housed under one roof: 1) technology commercialization, 2) the USC/Columbia Technology Incubator, 3) the Innovista Research campus, and 4) the Corporate Solutions Group.
Under this organizational structure, the Office of Economic Engagement builds academic and industry partnerships, facilitates the commercialization of research, connects new and existing businesses with university talent and resources, and fosters entrepreneurship and small business development.
This year, the University of South Carolina is starting a new graduate program, the MS in Technology Innovation and Entrepreneurial Engineering. It is the only graduate program in the State of South Carolina that places a high premium on students with an engineering and science background, blending their technical and business skills in an entrepreneurial way.
Industry subject matter experts to cover what businesses need to know about state industry see more
GREENVILLE, SC – February 14, 2018 – SCBIO will host a half-day program March 14, 2018 -- South Carolina Life Sciences Boot Camp: Essentials of a Growing Industry – to inform and update businesses and professionals from across the state on opportunities, trends and issues facing South Carolina’s fastest-growing industry segment.
To be held at the University of South Carolina’s Arnold School of Public Health in Columbia, the program will run from 8:30 a.m. until 12:30 p.m. and will feature a light breakfast followed by presentations from over half a dozen noted life sciences industry leaders. Confirmed presenters and their topics are:
- Burnie Maybank, Author of the SC Life Sciences Act; Partner, Nexsen Pruet, “Life Sciences industry Economic Development Incentives”
- Stephanie Yarbrough, Partner, Womble Bond Dickinson, “M&A 101 in the Life Sciences Space”
- Kathryn Cole Becker, Principal, Translational Science Solutions, “FDA 101 for Medical Devices”
- Jeff Stover, Partner, Haynsworth Sinkler Boyd, “IP Essentials for Life Sciences”
- John Osborne, Partner, Good Growth Capital, “Introduction to Life Science Innovation & Entrepreneurship”
- Public Policy Hot Topics – Speaker to be announced
Attendance is free to SCBIO members and employees of SCBIO member companies, and available for only $75 to Non-Members. Advance registration is required, and space is limited. To register, visit www.SCBIO.org/Events.
SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products. The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.
SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations. SCBIO’s diverse membership is leading research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.
For additional information on SCBIO, visit www.SCBIO.org.
Nephron announces 5% salary increases thanks to tax cuts law see more
WEST COLUMBIA, S.C. – Nephron Pharmaceuticals Corporation (Nephron) CEO Lou Kennedy today announced five percent increases for all employees with the exception of commissioned employees. The raises are a direct result of the Tax Cuts and Jobs Act that was signed into law last week by President Donald Trump.
“We are excited that the Tax Cuts and Jobs Act has given us an opportunity to recognize their hard work and sacrifices with well-deserved raises”, said Lou Kennedy, CEO of Nephron.
Elected officials – including The Honorable Henry McMaster, Governor of South Carolina, U.S. Senator Lindsey Graham, Congressman Joe Wilson, state legislators and local elected officials – joined Kennedy and Nephron employees for today’s announcement celebration at the company’s West Columbia headquarters. Both of South Carolina’s U.S. Senators and six of the state’s seven members of the U.S. House of Representatives voted in favor of the Tax Cuts and Jobs Act.
"I am grateful that the tax cuts House Republicans worked so hard to pass have had an immediate impact in the district,” said Congressman Joe Wilson. “I congratulate Lou and Bill Kennedy, as well as Nephron's entire team, on today’s announcement, and I wish them continued success.”
Nephron is a manufacturer of respiratory and compounded 503B outsourcing medications that employs 640 people in West Columbia. The company, which launched 34 new products in 2017, recently announced a $12.5 million expansion and expects to add 125 additional employees by June 2018.
Fifty percent of Nephron employees attended South Carolina universities or technical colleges. Nephron founder Bill Kennedy and CEO Lou Kennedy are University of South Carolina graduates and South Carolinians. The company is part of the life sciences industry in the State. This industry has a total $11.4 billion annual impact on the State economy.
For more information about Nephron, visit http://www.nephronpharm.com.